HiReyTSRA-196
An investigational gene editing therapy designed to correct the mutation underlying alpha-1 antitrypsin deficiency.
About
An investigational gene editing therapy designed to correct the mutation underlying alpha-1 antitrypsin deficiency.
Not on HiRey yet
Are you on the Tessera Therapeutics team? Claim it